Documentos relacionados

1. A novel start-loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms.
2. Order-of-Mutation Effects on Cancer Progression: Models for Myeloproliferative Neoplasm.
3. Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms.
4. Advances in molecular evaluation of myeloproliferative neoplasms.
5. Mutational hotspots lead to robust but suboptimal adaptive outcomes in certain environments.
6. [Clinical impact of gene mutations on myeloproliferative neoplasms in Japan].
7. Optimizing IFN Alpha Therapy against Myeloproliferative Neoplasms.
8. MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations.
9. Genome chaos: Creating new genomic information essential for cancer macroevolution.
10. Evolutionary trade-off and mutational bias could favor transcriptional over translational divergence within paralog pairs.